Search hospitals > North Carolina > Jacksonville
Southeastern Medical Oncology Center-Jacksonville
Claim this profileJacksonville, North Carolina 28546
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Relapse
173 reported clinical trials
2 medical researchers
Summary
Southeastern Medical Oncology Center-Jacksonville is a medical facility located in Jacksonville, North Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Breast cancer, Lung Cancer, Relapse and other specialties. Southeastern Medical Oncology Center-Jacksonville is involved with conducting 173 clinical trials across 376 conditions. There are 2 research doctors associated with this hospital, such as Samer S. Kasbari and Nagesh H. Jayaram.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Samer S. KasbariSoutheastern Medical Oncology Center-Clinton6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
72 reported clinical trials
132 drugs studied
Nagesh H. JayaramSoutheastern Medical Oncology Center-Clinton10 years of reported clinical research
Studies Papillary Adenoma
Studies Colorectal Cancer
2 reported clinical trials
6 drugs studied
Clinical Trials running at Southeastern Medical Oncology Center-Jacksonville
Breast Cancer
Cancer
Breast cancer
Parotid Gland Cancer
Lung Cancer
Skin Cancer
Esophageal cancer
Laryngeal Cancer
Testicular cancer
Cutaneous Melanoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Southeastern Medical Oncology Center-Jacksonville?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.